Skip to main content

Addex Therapeutics Ltd.

ADXN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001574232

No open-market purchases or sales by Addex Therapeutics Ltd. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $274 in total; no superinvestor holds it.

Superinvestors holding ADXN, Q2 2026

See all superinvestors

No superinvestor reported holding ADXN in Q2 2026.